Optimization and dissolution performance of spray-dried naproxen nano-crystals

International Journal of Pharmaceutics

Volumn 486, Issue 1-2, 2015, Pages 159-166

  Kumar, Sumit ^a   Shen, Jie ^a   Zolnik, Banu ^b   Sadrieh, Nakissa ^b   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

DoE; Nano crystalline; Nano suspension; Re dispersion; Spray drying; Spray dried powder

Indexed keywords

LACTOSE; NANOCRYSTAL; NAPROXEN; POLYSORBATE 80; TREHALOSE; HYDROXYPROPYLMETHYLCELLULOSE; NANOPARTICLE; POLYSORBATE; POWDER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MOISTURE; PARTICLE SIZE; PRIORITY JOURNAL; SPRAY DRYING; SUSPENSION; CHEMISTRY; DRUG FORMULATION; POWDER; SOLUBILITY;

DRUG COMPOUNDING; HYPROMELLOSE DERIVATIVES; LACTOSE; NANOPARTICLES; NAPROXEN; PARTICLE SIZE; POLYSORBATES; POWDERS; SOLUBILITY; TREHALOSE;

EID: 84926135981     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.03.047     Document Type: Article

References (21)

1. M.V. Chaubal, and C. Popescu Conversion of nanosuspensions into dry powders by spray drying: a case study Pharm. Res. 25 October (10) 2008 2302 2308
2. P. Gribbon, and A. Sewing High-throughput drug discovery: what can we expect from HTS? Drug Discov. Today 10 January 1 (1) 2005 17 22
3. J. Jinno, N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G.G. Liversidge, K. Hiqaki, and T. Kimura Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs J. Control. Release 111 2006 56 64
4. J.E. Kipp The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs Int. J. Pharm. 284 October 13 (1-2) 2004 109 122
5. S. Kumar, and D.J. Burgess Nanosuspension: Controlled release science and technology J. Wright, D.J. Burgess, Long Acting Injections and Implants 2012 CRS Press Springer 239 262 (Chapter 13)
6. S. Kumar, and D.J. Burgess Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions Int. J. Pharm. 466 May (1-2) 2014 223 232
7. S. Kumar, R. Gokhale, and D.J. Burgess Formulation parameters of crystalline nanosuspensions on spray drying processing: A DoE approach Int. J. Pharm. 464 April (1-2) 2014 34 45
8. S. Kumar, R. Gokhale, and D.J. Burgess Sugars as bulking agents to prevent nano-crystal aggregation during spray or freeze-drying Int. J. Pharm. 471 August (1-2) 2014 303 311
9. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 March 1 (1-3) 2001 3 26
10. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 July-August (1) 2000 235 249
11. C. Lipinski Poor aqueous solubility-an industry wide problem in drug discovery Am. Pharm. Rev. 5 2002 82 85
12. G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int. J. Pharm. 125 1995 91 97
13. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 February (2) 2003 113 120
14. A. Noyes, and W. Whitney The Rate of Solution of Solid Substance in Their Own Solutions 1897 Marcel Dekker New York
15. J.S. Song, and Y.-T. Sohn Crystal forms of naproxen Pharm. Res. 34 January (1) 2011 87 90
16. S.W. Thomson On the equilibrium of vapour at a curved surface of liquid Philos. Mag. 42 Series 4 (282) 1871 448 452
17. B. Van Eerdenbrugh, L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter Drying of crystalline drug nanosuspensions - the importance of surface hydrophobicity on dissolution behavior upon redispersion Eur. J. Pharm. Sci. 35 September 2 (1-2) 2008 127 135
18. B. Van Eerdenbrugh, S. Vercruysse, J.A. Martens, J. Vermant, L. Froyen, and J. Van Humbeeck Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole Eur. J. Pharm. Biopharm. 70 October (2) 2008 590 596
19. B. Van Eerdenbrugh, J. Vermant, J.A. Martens, L. Froyen, J.V. Humbeeck, and G. Van den Mooter Solubility increases associated with crystalline drug nanoparticles: methodologies and significance Mol. Pharm. 7 October 4 (5) 2010 1858 1870
20. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 380 October 1 (1-2) 2009 216 222
21. S. Verma, B.D. Huey, and D.J. Burgess Scanning probe microscopy method for nanosuspension stabilzier selection Langmuir 25 November (21) 2009 12481 12487